NCT00633581

Brief Summary

Fatigue is one of the most frequently observed symptoms for company workers, and oxidative stress is regarded as one of its cause. Vitamin C is a well-known antioxidant, and the investigators seek for evidence of the efficacy of high dose vitamin C parenteral supplement on fatigue symptoms of company workers after work.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2008

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 12, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

April 10, 2009

Status Verified

April 1, 2009

Enrollment Period

2 months

First QC Date

March 3, 2008

Last Update Submit

April 8, 2009

Conditions

Keywords

fatigueascorbic acidoxidative stress

Outcome Measures

Primary Outcomes (1)

  • Degree of fatigue at the point of time with visual analogue scale from 0 to 10

    Before intravenous vitamin C injection and right after completing injections, and one day later

Secondary Outcomes (2)

  • Reactive oxygen species

    Before intravenous vitamin C injections, right after completing injections, and one day later

  • Plasma vitamin C level

    Before intravenous vitamin C injections and right after completing injections

Study Arms (2)

1

EXPERIMENTAL

Intravenous injections of 10 grams(20ml as a solution) of vitamin C with 100ml of normal saline over 30 minutes.

Dietary Supplement: Ascorbic acid (Vitamin C)

2

PLACEBO COMPARATOR

Intravenous injections of 120ml of normal saline over 30 minutes.

Dietary Supplement: Normal saline

Interventions

Ascorbic acid (Vitamin C)DIETARY_SUPPLEMENT

Single intravenous injection of vitamin C 10g(20ml) with 100ml of normal saline over 30 minutes

Also known as: Ascorbic acid, Merit C
1
Normal salineDIETARY_SUPPLEMENT

Single intravenous injection of 120ml of normal saline over 30 minutes

2

Eligibility Criteria

Age20 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Company workers working at least 5 days a week from morning to evening
  • Volunteers who provided written informed consent

You may not qualify if:

  • Acute illness
  • Chronic disease such as diabetes, hypertension, liver disease, or renal disease
  • Previous history of renal stone or gout
  • Pregnant or lactating women
  • Hypersensitivity to vitamins or intravenous injections
  • History of vitamin supplements orally or parenterally within 2 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DongGuk University International Hospital

Goyang-si, Gyeonggi-do, 410-773, South Korea

Location

Related Publications (16)

  • Bates DW, Schmitt W, Buchwald D, Ware NC, Lee J, Thoyer E, Kornish RJ, Komaroff AL. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993 Dec 27;153(24):2759-65.

    PMID: 8257251BACKGROUND
  • Skapinakis P, Lewis G, Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Am J Psychiatry. 2000 Sep;157(9):1492-8. doi: 10.1176/appi.ajp.157.9.1492.

    PMID: 10964867BACKGROUND
  • Logan AC. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2001 Feb;6(1):4-6. No abstract available.

    PMID: 11207453BACKGROUND
  • Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000;5(1):35-41. doi: 10.1179/rer.2000.5.1.35.

    PMID: 10905542BACKGROUND
  • Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). 2005 Jan;55(1):20-31. doi: 10.1093/occmed/kqi013.

    PMID: 15699087BACKGROUND
  • Grossi G, Perski A, Evengard B, Blomkvist V, Orth-Gomer K. Physiological correlates of burnout among women. J Psychosom Res. 2003 Oct;55(4):309-16. doi: 10.1016/s0022-3999(02)00633-5.

    PMID: 14507541BACKGROUND
  • Avalos I, Chung CP, Oeser A, Milne GL, Morrow JD, Gebretsadik T, Shintani A, Yu C, Stein CM. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus. 2007;16(3):195-200. doi: 10.1177/0961203306075802.

    PMID: 17432105BACKGROUND
  • Powers SK, Hamilton K. Antioxidants and exercise. Clin Sports Med. 1999 Jul;18(3):525-36. doi: 10.1016/s0278-5919(05)70166-6.

    PMID: 10410839BACKGROUND
  • Mantovani G, Maccio A, Madeddu C, Mura L, Massa E, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J Cell Mol Med. 2002 Oct-Dec;6(4):570-82. doi: 10.1111/j.1582-4934.2002.tb00455.x.

    PMID: 12611641BACKGROUND
  • Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005 Sep 1;39(5):584-9. doi: 10.1016/j.freeradbiomed.2005.04.020.

    PMID: 16085177BACKGROUND
  • Bryer SC, Goldfarb AH. Effect of high dose vitamin C supplementation on muscle soreness, damage, function, and oxidative stress to eccentric exercise. Int J Sport Nutr Exerc Metab. 2006 Jun;16(3):270-80. doi: 10.1123/ijsnem.16.3.270.

    PMID: 16948483BACKGROUND
  • Sanchez-Moreno C, Cano MP, de Ancos B, Plaza L, Olmedilla B, Granado F, Martin A. Consumption of high-pressurized vegetable soup increases plasma vitamin C and decreases oxidative stress and inflammatory biomarkers in healthy humans. J Nutr. 2004 Nov;134(11):3021-5. doi: 10.1093/jn/134.11.3021.

    PMID: 15514269BACKGROUND
  • Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer. 2004 Jul;40(11):1713-23. doi: 10.1016/j.ejca.2004.02.029.

    PMID: 15251161BACKGROUND
  • Mayland CR, Bennett MI, Allan K. Vitamin C deficiency in cancer patients. Palliat Med. 2005 Jan;19(1):17-20. doi: 10.1191/0269216305pm970oa.

    PMID: 15690864BACKGROUND
  • Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Rimm EB, Ascherio A. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr. 2004 Dec;80(6):1508-20. doi: 10.1093/ajcn/80.6.1508.

    PMID: 15585762BACKGROUND
  • Suh SY, Bae WK, Ahn HY, Choi SE, Jung GC, Yeom CH. Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial. Nutr J. 2012 Jan 20;11:7. doi: 10.1186/1475-2891-11-7.

MeSH Terms

Conditions

Fatigue

Interventions

Ascorbic AcidSaline Solution

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydratesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Chang H Yeom, MD, PhD

    KwanDong University Myungji Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 3, 2008

First Posted

March 12, 2008

Study Start

March 1, 2008

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

April 10, 2009

Record last verified: 2009-04

Locations